ARTICLE | Distillery Therapeutics
Pulmonary
October 24, 2017 7:02 PM UTC
Mouse studies suggest inhibiting ADAM10 could help treat idiopathic pulmonary fibrosis (IPF). In a mouse model of IPF, an ADAM10 inhibitor tool compound decreased fibrosis in the lung and increased su...
BCIQ Target Profiles